Angelman syndrome is a rare neuro-genetic disorder caused by a loss of function of the UBE3A gene that happens during fetal development, and causes developmental delays, intellectual disability ...

Angelman syndrome, which affects 1 in 15,000 people, is a rare neurogenetic disorder that stems from a mutation or deletion of a gene in the 15th chromosome, called the ubiquitin protein ligase ...

A child with Angelman syndrome will begin to show signs of delayed development at around 6 to 12 months of age, such as being unable to sit unsupported or make babbling noises.

Angelman syndrome is a rare genetic condition which causes delayed development, problems with speech and balance, mental disability and seizures. Colin Farrell’s son, who he shares with model ...

Ultragenyx is one of the few companies developing a treatment for Angelman syndrome, a genetic condition that causes delayed development, problems with speech and balance, mental disability, and ...

Colin Farrell Reveals Son James Lives With Rare Disorder During a new interview, the actor revealed that his son has been living with a genetic disorder. Learn more about Angelman Syndrome, here.

In a discovery that opens the door to a less invasive way of treating some serious disorders before birth, UC San Francisco scientists have found that delivering medicine through amniotic fluid is as ...

International Angelman Day, a celebration to create awareness of Angelman syndrome, a rare neurogenetic disorder, is Feb. 15. Buildings and landmarks around the metro area will be lit up in blue ...

Cyclists led by Charlie Nuck will arrive in Bar Harbor Saturday to raise awareness and funds for the rare neurogenetic ...

The actor's son James has a rare genetic disorder called Angelman syndrome. — -- Colin Farrell's latest movie role as a torn father has him opening up about his real-life fatherhood journey ...

Angelman syndrome, which affects 1 in 15,000 people, is a rare neurogenetic disorder that stems from a mutation or deletion of a gene in the 15th chromosome, called the ubiquitin protein ligase E3A ...